These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19309119)

  • 21. Interpretation of protein/ligand crystal structure using QM/MM calculations: case of HIV-1 protease/metallacarborane complex.
    Fanfrlík J; Brynda J; Rezác J; Hobza P; Lepsík M
    J Phys Chem B; 2008 Nov; 112(47):15094-102. PubMed ID: 18975888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical protonation states in the active site of HIV-1 protease: a computational study.
    Czodrowski P; Sotriffer CA; Klebe G
    J Chem Inf Model; 2007; 47(4):1590-8. PubMed ID: 17503762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of potency of protease inhibitors using free energy simulations with polarizable quantum mechanics-based ligand charges and a hybrid water model.
    Das D; Koh Y; Tojo Y; Ghosh AK; Mitsuya H
    J Chem Inf Model; 2009 Dec; 49(12):2851-62. PubMed ID: 19928916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor- and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations.
    Ahmed L; Rasulev B; Turabekova M; Leszczynska D; Leszczynski J
    Org Biomol Chem; 2013 Sep; 11(35):5798-808. PubMed ID: 23900343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insight into analysis of interactions of saquinavir with HIV-1 protease in comparison between the wild-type and G48V and G48V/L90M mutants based on QM and QM/MM calculations.
    Saen-oon S; Aruksakunwong O; Wittayanarakul K; Sompornpisut P; Hannongbua S
    J Mol Graph Model; 2007 Nov; 26(4):720-7. PubMed ID: 17543558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of non-natural D-amino acid derivatives and allophenylnorstatine-dimethylthioproline scaffold in HIV protease inhibitors have high efficacy in mutant HIV.
    Nakatani S; Hidaka K; Ami E; Nakahara K; Sato A; Nguyen JT; Hamada Y; Hori Y; Ohnishi N; Nagai A; Kimura T; Hayashi Y; Kiso Y
    J Med Chem; 2008 May; 51(10):2992-3004. PubMed ID: 18426195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational proteomics analysis of binding mechanisms and molecular signatures of the HIV-1 protease drugs.
    Verkhivker G
    Artif Intell Med; 2009; 45(2-3):197-206. PubMed ID: 18926674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple clustering technique to improve QSAR model selection and predictivity: application to a receptor independent 4D-QSAR analysis of cyclic urea derived inhibitors of HIV-1 protease.
    Senese CL; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(6):2180-93. PubMed ID: 14632470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated molecular simulation based binding affinity calculator for ligand-bound HIV-1 proteases.
    Sadiq SK; Wright D; Watson SJ; Zasada SJ; Stoica I; Coveney PV
    J Chem Inf Model; 2008 Sep; 48(9):1909-19. PubMed ID: 18710212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maximum common binding modes (MCBM): consensus docking scoring using multiple ligand information and interaction fingerprints.
    Renner S; Derksen S; Radestock S; Mörchen F
    J Chem Inf Model; 2008 Feb; 48(2):319-32. PubMed ID: 18211051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small-sized human immunodeficiency virus type-1 protease inhibitors containing allophenylnorstatine to explore the S2' pocket.
    Hidaka K; Kimura T; Abdel-Rahman HM; Nguyen JT; McDaniel KF; Kohlbrenner WE; Molla A; Adachi M; Tamada T; Kuroki R; Katsuki N; Tanaka Y; Matsumoto H; Wang J; Hayashi Y; Kempf DJ; Kiso Y
    J Med Chem; 2009 Dec; 52(23):7604-17. PubMed ID: 19954246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into docking and scoring neuronal alpha4beta2 nicotinic receptor agonists using molecular dynamics simulations and QM/MM calculations.
    Sgrignani J; Bonaccini C; Grazioso G; Chioccioli M; Cavalli A; Gratteri P
    J Comput Chem; 2009 Nov; 30(15):2443-54. PubMed ID: 19360794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the dimerization and active site of HIV-1 protease by secondary metabolites from the Vietnamese mushroom Ganoderma colossum.
    El Dine RS; El Halawany AM; Ma CM; Hattori M
    J Nat Prod; 2009 Nov; 72(11):2019-23. PubMed ID: 19813754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interpreting trends in the binding of cyclic ureas to HIV-1 protease.
    Mardis KL; Luo R; Gilson MK
    J Mol Biol; 2001 Jun; 309(2):507-17. PubMed ID: 11371168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Energy minimum theorem based on AGA, Lyapunov and force field for CADD techniques.
    Sung WT; Liu YF
    Comput Biol Med; 2010 Feb; 40(2):215-22. PubMed ID: 20047735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors.
    Li D; Liu MS; Ji B; Hwang K; Huang Y
    J Chem Phys; 2009 Jun; 130(21):215102. PubMed ID: 19508101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding affinity prediction of non-peptide inhibitors of HIV-1 protease using COMBINE model introduced from peptide inhibitors.
    Nakamura S; Nakanishi I; Kitaura K
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6334-7. PubMed ID: 17027266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A semiempirical free energy force field with charge-based desolvation.
    Huey R; Morris GM; Olson AJ; Goodsell DS
    J Comput Chem; 2007 Apr; 28(6):1145-52. PubMed ID: 17274016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystal structure of chemically synthesized HIV-1 protease and a ketomethylene isostere inhibitor based on the p2/NC cleavage site.
    Torbeev VY; Mandal K; Terechko VA; Kent SB
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4554-7. PubMed ID: 18657969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein NMR chemical shift calculations based on the automated fragmentation QM/MM approach.
    He X; Wang B; Merz KM
    J Phys Chem B; 2009 Jul; 113(30):10380-8. PubMed ID: 19575540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.